🇺🇸 FDA
Pipeline program

E7766

E7766-G000-101

Phase 1 small_molecule terminated

Quick answer

E7766 for Lymphoma is a Phase 1 program (small_molecule) at Eisai Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Eisai Co.,
Indication
Lymphoma
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials